Australia markets closed

Rocket Pharmaceuticals, Inc. (RCKT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
22.48+1.63 (+7.82%)
At close: 04:00PM EDT
22.69 +0.21 (+0.93%)
Pre-market: 08:31AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-249,314
-245,595
-221,863
-169,069
-139,700
-
Depreciation & amortisation
7,679
7,098
6,266
5,373
6,250
-
Stock-based compensation
40,743
39,406
31,009
29,237
18,567
-
Change in working capital
16,374
13,458
6,076
-3,386
9,924
-
Other working capital
-209,697
-211,388
-186,761
-128,878
-103,699
-
Other non-cash items
-
-
-
13,534
29,320
3,602
Net cash provided by operating activities
-194,212
-194,916
-178,142
-121,163
-74,640
-
Cash flows from investing activities
Investments in property, plant and equipment
-15,485
-16,472
-8,619
-7,715
-29,059
-
Purchases of investments
-358,833
-390,920
-376,327
-245,875
-209,343
-
Sales/maturities of investments
348,007
309,326
272,894
272,443
141,811
-
Net cash used for investing activities
-26,311
-98,066
-69,326
18,853
-96,591
-
Cash flows from financing activities
Common stock issued
191,242
208,394
155,335
37,681
281,354
-
Common stock repurchased
-
0
-47
0
-72
-
Other financing activities
-
-
-
-
-851
-344
Net cash used provided by (used for) financing activities
191,242
208,401
155,288
37,681
282,989
-
Net change in cash
-29,281
-84,581
-92,180
-64,629
111,758
-
Cash at beginning of period
65,919
141,857
234,037
298,666
186,908
-
Cash at end of period
36,638
57,276
141,857
234,037
298,666
-
Free cash flow
Operating cash flow
-194,212
-194,916
-178,142
-121,163
-74,640
-
Capital expenditure
-15,485
-16,472
-8,619
-7,715
-29,059
-
Free cash flow
-209,697
-211,388
-186,761
-128,878
-103,699
-